Connection

A Venkatakrishnan to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications A Venkatakrishnan has written about Antibodies, Monoclonal, Humanized.
A Venkatakrishnan
Connection Strength
0.049
Antibodies, Monoclonal, Humanized
  1. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.